{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:05:59Z","timestamp":1790643959962,"version":"4.1.0"},"reference-count":280,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009991","name":"Jilin Province Department of Finance","doi-asserted-by":"publisher","award":["JLSWSRCZX2025-120"],"award-info":[{"award-number":["JLSWSRCZX2025-120"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phrs.2025.107960","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:09:43Z","timestamp":1758589783000},"page":"107960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Stem cells therapy in neurodegenerative and neuroimmune diseases: Current status of treatments and future prospects"],"prefix":"10.1016","volume":"221","author":[{"given":"Mingchao","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3291-1768","authenticated-orcid":false,"given":"Fengna","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107960_bib1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s40001-024-01987-1","article-title":"Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives","volume":"29","author":"Rahimi Darehbagh","year":"2024","journal-title":"Eur. J. Med Res"},{"key":"10.1016\/j.phrs.2025.107960_bib2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.27360","article-title":"Disease modification in parkinson's disease: current approaches, challenges, and future considerations","volume":"33","author":"Lang","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2025.107960_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Global, regional, and national burden of Alzheimer's disease and other dementias","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40265-023-01904-6","article-title":"Tofersen: first approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2025.107960_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/17582024.2024.2402216","article-title":"Tofersen for SOD1 ALS","volume":"14","author":"Everett","year":"2024","journal-title":"Neurodegener. Dis. Manag"},{"key":"10.1016\/j.phrs.2025.107960_bib6","first-page":"20150017","article-title":"Cell-based therapy technology classifications and translational challenges","volume":"370","author":"Mount","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib7","article-title":"Stem cell therapies: a new era in the treatment of multiple sclerosis","volume":"15","author":"Wu","year":"2024","journal-title":"Front Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-8697-2_1","article-title":"An update on the therapeutic potential of stem cells","volume":"1842","author":"Rameshwar","year":"2018","journal-title":"Methods Mol. Biol. (Clifton N. J. )"},{"key":"10.1016\/j.phrs.2025.107960_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12015-013-9443-6","article-title":"Progress in stem cell therapy for major human neurological disorders","volume":"9","author":"Mart\u00ednez-Morales","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2025.107960_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pneurobio.2011.08.005","article-title":"The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders","volume":"95","author":"Borlongan","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107960_bib12","first-page":"474","article-title":"CD34-positive stem cells: in the treatment of heart and vascular disease in human beings","volume":"38","author":"Mackie","year":"2011","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.phrs.2025.107960_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40291-024-00696-z","article-title":"Exagamglogene autotemcel: first approval","volume":"28","author":"Hoy","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib14","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1089\/scd.2015.0008","article-title":"Mesenchymal stem cell therapy for autoimmune disease: risks and rewards","volume":"24","author":"Munir","year":"2015","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.phrs.2025.107960_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.15283\/ijsc21032","article-title":"Therapeutic aspects of mesenchymal stem Cell-Based cell therapy with a focus on human amniotic epithelial cells in multiple sclerosis: a mechanistic review","volume":"14","author":"ArefNezhad","year":"2021","journal-title":"Int J. Stem Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031365","article-title":"The therapeutic mechanisms of mesenchymal stem cells in MS-A review focusing on neuroprotective properties","volume":"25","author":"Gavasso","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/14712598.2016.1196179","article-title":"Harnessing mesenchymal stem cell homing as an anticancer therapy","volume":"16","author":"Hagenhoff","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib18","first-page":"965","article-title":"Mesenchymal stem Cells-based Cell-free therapy targeting neuroinflammation","volume":"15","author":"Xu","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.phrs.2025.107960_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176719","article-title":"Mesenchymal stem cells biological and biotechnological advances: implications for clinical applications","volume":"977","author":"Pharoun","year":"2024","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107960_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11948-015-9666-9","article-title":"Human embryonic stem cell research: ethical views of buddhist, hindu and catholic leaders in Malaysia","volume":"22","author":"Sivaraman","year":"2016","journal-title":"Sci. Eng. Ethics"},{"key":"10.1016\/j.phrs.2025.107960_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092319","article-title":"Induced pluripotent stem cells (iPSCs)-Roles in regenerative therapies, disease modelling and drug screening","volume":"10","author":"Aboul-Soud","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/neup.12020","article-title":"Neural stem cell-based treatment for neurodegenerative diseases","volume":"33","author":"Kim","year":"2013","journal-title":"Neuropathology"},{"key":"10.1016\/j.phrs.2025.107960_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells13020112","article-title":"The role of stem cells as therapeutics for ischaemic stroke","volume":"13","author":"Ya","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13287-024-03825-x","article-title":"The roles of neural stem cells in myelin regeneration and repair therapy after spinal cord injury","volume":"15","author":"Li","year":"2024","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-4886(03)00037-2","article-title":"Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury","volume":"181","author":"Lu","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4103\/1673-5374.380874","article-title":"Neural stem cells promote neuroplasticity: a promising therapeutic strategy for the treatment of alzheimer's disease","volume":"19","author":"Chang","year":"2024","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.phrs.2025.107960_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042392","article-title":"Induced pluripotent stem cells in drug discovery and neurodegenerative disease modelling","volume":"25","author":"Beghini","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098386","article-title":"Molecular mechanisms underlying pluripotency and Self-Renewal of embryonic stem cells","volume":"24","author":"Varzideh","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13770-024-00627-3","article-title":"Advancements in human embryonic stem cell research: clinical applications and ethical issues","volume":"21","author":"Park","year":"2024","journal-title":"Tissue Eng. Regen. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41586-023-06914-8","article-title":"Modelling post-implantation human development to yolk sac blood emergence","volume":"626","author":"Hislop","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107960_bib31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.1293","article-title":"An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells","volume":"31","author":"Okita","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.scr.2018.03.002","article-title":"Generation of induced pluripotent stem cell line (ZZUi011-A) from urine sample of a normal human","volume":"29","author":"Sun","year":"2018","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.phrs.2025.107960_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/7651_2021_372","article-title":"Generation of human induced pluripotent stem cells using endothelial progenitor cells derived from umbilical cord blood and adult peripheral blood","volume":"2454","author":"Gao","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2025.107960_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13287-024-03794-1","article-title":"iPSCs chondrogenic differentiation for personalized regenerative Medicine: a literature review","volume":"15","author":"Ali","year":"2024","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","article-title":"Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003920","article-title":"Pluripotent stem cell-based cancer therapy: promise and challenges","volume":"4","author":"Sharkis","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","article-title":"iPSC-Derived human Microglia-like cells to study neurological diseases","volume":"94","author":"Abud","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107960_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107960_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098068","article-title":"Immunomodulatory mechanism and potential application of dental Pulp-Derived stem cells in Immune-Mediated diseases","volume":"24","author":"Min","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib40","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2025.107960_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2025.107960_bib42","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/stem.1409","article-title":"MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles","volume":"31","author":"Xin","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","article-title":"Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis","volume":"198","author":"Crigler","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cells12010120","article-title":"Molecular mechanisms and clinical application of multipotent stem cells for spinal cord injury","volume":"12","author":"Szymoniuk","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib45","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/stcltm\/szae045","article-title":"Exploring mesenchymal stem cells homing mechanisms and improvement strategies","volume":"13","author":"Sajjad","year":"2024","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/jmcb\/mju001","article-title":"Wnt signaling in midbrain dopaminergic neuron development and regenerative Medicine for parkinson's disease","volume":"6","author":"Arenas","year":"2014","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2025.107960_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WCO.0000000000000206","article-title":"Classification, diagnosis, and differential diagnosis of multiple sclerosis","volume":"28","author":"Katz Sand","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib48","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain a J. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.05.006","article-title":"Does the environment influence multiple sclerosis pathogenesis via UVB light and\/or induction of vitamin D?","volume":"329","author":"Breuer","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.107960_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2018.00477","article-title":"Genomic effects of the vitamin d receptor: potentially the link between vitamin D, immune cells, and multiple sclerosis","volume":"9","author":"Lu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2025.107960_bib51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jnr.24224","article-title":"Animal models of multiple sclerosis: focus on experimental autoimmune encephalomyelitis","volume":"96","author":"Bjelobaba","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2025.107960_bib52","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/jnr.24023","article-title":"Diversity of immune cell types in multiple sclerosis and its animal model: pathological and therapeutic implications","volume":"95","author":"Cheng","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2025.107960_bib53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.clinthera.2015.03.001","article-title":"New FDA-Approved Disease-Modifying therapies for multiple sclerosis","volume":"37","author":"English","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib54","first-page":"109","article-title":"Current concepts in multiple sclerosis therapy","volume":"7","author":"Sedal","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.phrs.2025.107960_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419826547","article-title":"Evolution of clinical trials in multiple sclerosis","volume":"12","author":"Zhang","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.phrs.2025.107960_bib56","first-page":"25","article-title":"A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future","volume":"68","author":"Gholamzad","year":"2019","journal-title":"Inflamm. Res. Off. J. Eur. Histamine Res. Soc. [Et. al. ]"},{"key":"10.1016\/j.phrs.2025.107960_bib57","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s12325-014-0149-1","article-title":"Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis","volume":"31","author":"Marziniak","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib58","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/eji.201646485","article-title":"Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis","volume":"46","author":"Martin","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.phrs.2025.107960_bib59","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/imj.12558","article-title":"Current management of relapsing-remitting multiple sclerosis","volume":"44","author":"Sedal","year":"2014","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.phrs.2025.107960_bib60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MS9.0000000000001490","article-title":"Immunological outcomes of autologous hematopoietic stem cell transplantation for multiple sclerosis: a systematic review","volume":"86","author":"Sai Santhosha Mrudula","year":"2024","journal-title":"Ann. Med Surg. (Lond. )"},{"key":"10.1016\/j.phrs.2025.107960_bib61","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fimmu.2018.00410","article-title":"Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant","volume":"9","author":"Massey","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107960_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103480","article-title":"Current knowledge on multiple sclerosis pathophysiology, disability progression assessment and treatment options, and the role of autologous hematopoietic stem cell transplantation","volume":"23","author":"Gakis","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2025.107960_bib63","article-title":"Immune reconstitution following autologous hematopoietic stem cell transplantation for multiple sclerosis: a review on behalf of the EBMT autoimmune diseases working party","volume":"12","author":"Cencioni","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107960_bib64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2016.06.005","article-title":"Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation","volume":"169","author":"Arruda","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.phrs.2025.107960_bib65","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3389\/fimmu.2018.00834","article-title":"Natural killer cells regulate Th17 cells after autologous hematopoietic stem cell transplantation for relapsing remitting multiple sclerosis","volume":"9","author":"Darlington","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107960_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105944","article-title":"Effects of multiple treatments with stem cell therapy in patients with multiple sclerosis","volume":"92","author":"Fan","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.phrs.2025.107960_bib67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00005-023-00675-y","article-title":"Effect of hematopoietic stem cell transplantation and Post-Transplantation cyclophosphamide on the microglia phenotype in rats with experimental allergic encephalomyelitis","volume":"71","author":"Kasare\u0142\u0142o","year":"2023","journal-title":"Arch. Immunol. Ther. Exp. (Warsz. )"},{"key":"10.1016\/j.phrs.2025.107960_bib68","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41593-024-01609-3","article-title":"Myeloid cell replacement is neuroprotective in chronic experimental autoimmune encephalomyelitis","volume":"27","author":"Mader","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2025.107960_bib69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13577-023-01006-1","article-title":"Cell replacement therapy with stem cells in multiple sclerosis, a systematic review","volume":"37","author":"Christodoulou","year":"2024","journal-title":"Hum. Cell"},{"key":"10.1016\/j.phrs.2025.107960_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103480","article-title":"Current knowledge on multiple sclerosis pathophysiology, disability progression assessment and treatment options, and the role of autologous hematopoietic stem cell transplantation","volume":"23","author":"Gakis","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2025.107960_bib71","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0140-6736(16)30169-6","article-title":"Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial","volume":"388","author":"Atkins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2025.107960_bib72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2018.18743","article-title":"Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued Disease-Modifying therapy on disease progression in patients with Relapsing-Remitting multiple sclerosis: a randomized clinical trial","volume":"321","author":"Burt","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2025.107960_bib73","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/jnnp-2018-319446","article-title":"Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis","volume":"90","author":"Moore","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107960_bib74","article-title":"Long-Term suppression of circulating proinflammatory cytokines in multiple sclerosis patients following autologous haematopoietic stem cell transplantation","volume":"12","author":"Hendrawan","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107960_bib75","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1177\/1352458518802544","article-title":"Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis","volume":"25","author":"Bose","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2025.107960_bib76","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cei.13358","article-title":"Self-reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center","volume":"198","author":"Ruiz-Arg\u00fcelles","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.phrs.2025.107960_bib77","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/acn3.51366","article-title":"aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis","volume":"8","author":"H\u00e4u\u00dfler","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib78","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/1352458517715811","article-title":"Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and White matter atrophy in multiple sclerosis","volume":"24","author":"Lee","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2025.107960_bib79","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/bmt.2011.208","article-title":"Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results","volume":"47","author":"Bowen","year":"2012","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.phrs.2025.107960_bib80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jamaneurol.2020.4025","article-title":"Autologous hematopoietic stem cell transplant in multiple sclerosis: recommendations of The National multiple sclerosis society","volume":"78","author":"Miller","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.696434","article-title":"Stem cell therapies for progressive multiple sclerosis","volume":"9","author":"Smith","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2025.107960_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/cells13181556","article-title":"The role of mesenchymal stem cells in modulating adaptive immune responses in multiple sclerosis","volume":"13","author":"Dadfar","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib83","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1002\/jcb.28670","article-title":"Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone-induced demyelination model","volume":"120","author":"Barati","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.phrs.2025.107960_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148568","article-title":"Th17 pathway as a target for multipotent stromal cell therapy in dogs: implications for translational research","volume":"11","author":"Kol","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2025.107960_bib85","article-title":"The mechanisms of mesenchymal stem cells in the treatment of experimental autoimmune encephalomyelitis","author":"Xue","year":"2024","journal-title":"Curr. Stem Cell Res Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib86","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/apm.13456","article-title":"Exploring the role of mesenchymal stem cells in modulating immune responses via treg and Th2 cell activation: insights from mouse model of multiple sclerosis","volume":"132","author":"Sadeghnejad","year":"2024","journal-title":"Apmis"},{"key":"10.1016\/j.phrs.2025.107960_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25136996","article-title":"Cellular therapy in experimental autoimmune encephalomyelitis as an adjuvant treatment to translate for multiple sclerosis","volume":"25","author":"Perussolo","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib88","first-page":"11","article-title":"Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination","volume":"198","author":"El-Akabawy","year":"2015","journal-title":"Ann. Anat. = Anat. Anz. Off. Organ Anat. Ges."},{"key":"10.1016\/j.phrs.2025.107960_bib89","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nature01552","article-title":"Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis","volume":"422","author":"Pluchino","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107960_bib90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neulet.2008.10.040","article-title":"Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration","volume":"448","author":"Gordon","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107960_bib91","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/cbin.12171","article-title":"Adipose-derived mesenchymal stem cells ameliorates experimental autoimmune encephalomyelitis via modulation of Th1\/Th17 and expansion of Th2\/Treg responses","volume":"48","author":"Zargarani","year":"2024","journal-title":"Cell Biol. Int"},{"key":"10.1016\/j.phrs.2025.107960_bib92","first-page":"157","article-title":"Intrathecal autologous bone Marrow-Derived hematopoietic stem cell therapy in neurological diseases","volume":"9","author":"Zakerinia","year":"2018","journal-title":"Int. J. Organ Transplant. Med."},{"key":"10.1016\/j.phrs.2025.107960_bib93","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ebiom.2018.02.002","article-title":"Phase I trial of intrathecal mesenchymal stem Cell-derived neural progenitors in progressive multiple sclerosis","volume":"29","author":"Harris","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2025.107960_bib94","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jcyt.2016.08.007","article-title":"Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis","volume":"18","author":"Harris","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.phrs.2025.107960_bib95","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/stcltm\/szab017","article-title":"Effects of mesenchymal stem cell transplantation on cerebrospinal fluid biomarkers in progressive multiple sclerosis","volume":"11","author":"Petrou","year":"2022","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib96","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1093\/brain\/awaa333","article-title":"Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis","volume":"143","author":"Petrou","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2025.107960_bib97","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12967-018-1433-7","article-title":"Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis","volume":"16","author":"Riordan","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2025.107960_bib98","doi-asserted-by":"crossref","DOI":"10.1177\/09636897241233045","article-title":"Human umbilical Cord-Derived mesenchymal stem cells in the treatment of multiple sclerosis patients: phase I\/II Dose-Finding clinical study","volume":"33","author":"Jamali","year":"2024","journal-title":"Cell Transpl."},{"key":"10.1016\/j.phrs.2025.107960_bib99","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/13524585221122156","article-title":"Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis","volume":"29","author":"Cohen","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2025.107960_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-00590-6","article-title":"Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial","volume":"15","author":"Shokati","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib101","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jcyt.2017.08.007","article-title":"Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis","volume":"20","author":"Sarkar","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.phrs.2025.107960_bib102","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/glia.23624","article-title":"Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination","volume":"67","author":"Rivera","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2025.107960_bib103","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/1352458517711276","article-title":"Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro","volume":"24","author":"Redondo","year":"2018","journal-title":"Mult. Scler. (Houndmills Basingstoke Engl. )"},{"key":"10.1016\/j.phrs.2025.107960_bib104","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1089\/scd.2016.0020","article-title":"Mesenchymal Stromal\/Stem cells do not ameliorate experimental autoimmune encephalomyelitis and are not detectable in the central nervous system of transplanted mice","volume":"25","author":"Abramowski","year":"2016","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.phrs.2025.107960_bib105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1474-4422(21)00301-X","article-title":"Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial","volume":"20","author":"Uccelli","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib106","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02563-8","article-title":"Neural stem cells derived from primitive mesenchymal stem cells reversed disease symptoms and promoted neurogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"12","author":"Brown","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib107","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.immuni.2011.06.011","article-title":"Leukemia inhibitory factor inhibits t helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease","volume":"35","author":"Cao","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2025.107960_bib108","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1172\/JCI92387","article-title":"Neural precursor cell-secreted TGF-\u03b22 redirects inflammatory monocyte-derived cells in CNS autoimmunity","volume":"127","author":"De Feo","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2025.107960_bib109","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.expneurol.2008.11.017","article-title":"Neural stem\/progenitor cells modulate immune responses by suppressing t lymphocytes with nitric oxide and prostaglandin E2","volume":"216","author":"Wang","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104868","article-title":"Regulatory t cells promote remyelination in the murine experimental autoimmune encephalomyelitis model of multiple sclerosis following human neural stem cell transplant","volume":"140","author":"McIntyre","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2025.107960_bib111","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41591-022-02097-3","article-title":"Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study","volume":"29","author":"Genchi","year":"2023","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib112","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.stem.2023.11.001","article-title":"Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis","volume":"30","author":"Leone","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2025.107960_bib113","first-page":"1","article-title":"A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells","volume":"11","author":"Shroff","year":"2018","journal-title":"Stem Cells Cloning"},{"key":"10.1016\/j.phrs.2025.107960_bib114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jbmr.2318","article-title":"SDF-1\/CXCR4 axis in Tie2-lineage cells including endothelial progenitor cells contributes to bone fracture healing","volume":"30","author":"Kawakami","year":"2015","journal-title":"J. Bone Min. Res"},{"key":"10.1016\/j.phrs.2025.107960_bib115","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jnr.10691","article-title":"Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat","volume":"73","author":"Chen","year":"2003","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.phrs.2025.107960_bib116","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/stem.245","article-title":"Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury","volume":"28","author":"Sharp","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003145","article-title":"Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis","volume":"3","author":"Aharonowiz","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107960_bib118","doi-asserted-by":"crossref","first-page":"944","DOI":"10.12659\/AJCR.899745","article-title":"Transplantation of human embryonic stem cells in patients with multiple sclerosis and lyme disease","volume":"17","author":"Shroff","year":"2016","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib119","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2007.09.008","article-title":"Human embryonic stem cells: an experimental and therapeutic resource for neurological disease","volume":"265","author":"Joannides","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib120","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.expneurol.2008.04.040","article-title":"Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy","volume":"212","author":"Hattiangady","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib121","doi-asserted-by":"crossref","first-page":"15472","DOI":"10.1073\/pnas.0900141106","article-title":"Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice","volume":"106","author":"Baraban","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107960_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213476","article-title":"Stem-Cell-Based therapy: the celestial weapon against neurological disorders","volume":"11","author":"Zayed","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib123","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/glia.21159","article-title":"Differentiation of induced pluripotent stem cells into functional oligodendrocytes","volume":"59","author":"Czepiel","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2025.107960_bib124","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1038\/ncomms3597","article-title":"iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF","volume":"4","author":"Laterza","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107960_bib125","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s11427-016-0114-9","article-title":"Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells","volume":"59","author":"Zhang","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib126","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.stemcr.2014.06.012","article-title":"Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells","volume":"3","author":"Douvaras","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib127","series-title":"in Diagnosis and Management in Dementia","first-page":"365","author":"Alexiou","year":"2020"},{"key":"10.1016\/j.phrs.2025.107960_bib128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5507\/bp.2012.055","article-title":"Epidemiological of and risk factors for alzheimer's disease: a review","volume":"156","author":"Povova","year":"2012","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czechoslov."},{"key":"10.1016\/j.phrs.2025.107960_bib129","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2025.107960_bib130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12974-019-1494-4","article-title":"Antibiotics, gut microbiota, and alzheimer's disease","volume":"16","author":"Angelucci","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2025.107960_bib131","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.2174\/1568026620666200601161703","article-title":"Emerging proof of protein misfolding and interactions in multifactorial alzheimer's disease","volume":"20","author":"Uddin","year":"2020","journal-title":"Curr. Top. Med Chem."},{"key":"10.1016\/j.phrs.2025.107960_bib132","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.124","article-title":"Stem cell therapy for alzheimer's disease and related disorders: current status and future perspectives","volume":"47","author":"Tong","year":"2015","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib133","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.25172","article-title":"High complement levels in astrocyte-derived exosomes of alzheimer disease","volume":"83","author":"Goetzl","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib134","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2174\/1871527311312050008","article-title":"Innate immunity in alzheimer's disease: a complex affair","volume":"12","author":"Guillot-Sestier","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.phrs.2025.107960_bib135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imcb.12301","article-title":"The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of alzheimer's disease","volume":"98","author":"Webers","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.phrs.2025.107960_bib136","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer's disease: experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2025.107960_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112956","article-title":"Rescue of alzheimer's disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells","volume":"42","author":"Mishra","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib138","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1523\/JNEUROSCI.5147-10.2011","article-title":"Long-term in vivo imaging of \u03b2-amyloid plaque appearance and growth in a mouse model of cerebral \u03b2-amyloidosis","volume":"31","author":"Hefendehl","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107960_bib139","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00401-012-1047-8","article-title":"Amyloid plaque formation precedes dendritic spine loss","volume":"124","author":"Bittner","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2025.107960_bib140","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.neurobiolaging.2014.06.004","article-title":"Isolation of glia from alzheimer's mice reveals inflammation and dysfunction","volume":"35","author":"Orre","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2025.107960_bib141","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107960_bib142","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature06616","article-title":"Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of alzheimer's disease","volume":"451","author":"Meyer-Luehmann","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107960_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060921","article-title":"Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology","volume":"8","author":"Krabbe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107960_bib144","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/nn.4142","article-title":"Do glia drive synaptic and cognitive impairment in disease?","volume":"18","author":"Chung","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2025.107960_bib145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2025.107960_bib146","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/glia.23074","article-title":"Microglia contributes to plaque growth by cell death due to uptake of amyloid \u03b2 in the brain of alzheimer's disease mouse model","volume":"64","author":"Baik","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2025.107960_bib147","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.410100605","article-title":"Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent","volume":"10","author":"Wisniewski","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib148","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.stem.2023.07.006","article-title":"A cell therapy approach to restore microglial Trem2 function in a mouse model of alzheimer's disease","volume":"30","author":"Yoo","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2025.107960_bib149","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1038\/s41467-024-52301-w","article-title":"Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an alzheimer's disease mouse model","volume":"15","author":"Milazzo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107960_bib150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fnins.2015.00417","article-title":"Neuroinflammatory paradigms in lysosomal storage diseases","volume":"9","author":"Bosch","year":"2015","journal-title":"Front Neurosci."},{"key":"10.1016\/j.phrs.2025.107960_bib151","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.25161","article-title":"Metallothioneins are neuroprotective agents in lysosomal storage disorders","volume":"83","author":"Cavalca","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib152","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/brain\/awx311","article-title":"Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy","volume":"141","author":"Holley","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2025.107960_bib153","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4252\/wjsc.v12.i8.787","article-title":"Stem cell therapy for alzheimer's disease","volume":"12","author":"Liu","year":"2020","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib154","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbi.2024.08.047","article-title":"Neuroprotective effects of mesenchymal stromal cells in mouse models of alzheimer's disease: the mediating role of gut microbes and their metabolites via the Microbiome-Gut-Brain axis","volume":"122","author":"Xing","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107960_bib155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10238-015-0375-0","article-title":"Wharton's Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-\u03b2 deposition in an APP\/PS1 transgenic mouse model","volume":"16","author":"Xie","year":"2016","journal-title":"Clin. Exp. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib156","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1089\/scd.2012.0633","article-title":"Cell and gene therapy in alzheimer's disease","volume":"22","author":"Glat","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.phrs.2025.107960_bib157","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbr.2016.12.021","article-title":"Human umbilical cord mesenchymal stem cells transplantation improves cognitive function in alzheimer's disease mice by decreasing oxidative stress and promoting hippocampal neurogenesis","volume":"320","author":"Cui","year":"2017","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.phrs.2025.107960_bib158","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fphar.2019.00355","article-title":"Intravenously injected mesenchymal stem cells penetrate the brain and treat Inflammation-Induced brain damage and memory impairment in mice","volume":"10","author":"Lykhmus","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.107960_bib159","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1567205013666161004151416","article-title":"Human umbilical cord stem cell xenografts improve cognitive decline and reduce the amyloid burden in a mouse model of alzheimer's disease","volume":"14","author":"Boutajangout","year":"2017","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.phrs.2025.107960_bib160","doi-asserted-by":"crossref","DOI":"10.1002\/alz.057581","article-title":"Safety and efficacy of Lomecel-B in patients with mild Alzheimer\u2019s disease: results of a double-blinded, randomized, placebo-controlled phase 1 clinical trial","volume":"17","author":"Oliva Jr","year":"2021","journal-title":"Alzheimer's. Dement."},{"key":"10.1016\/j.phrs.2025.107960_bib161","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/alz.12651","article-title":"Results and insights from a phase I clinical trial of Lomecel-B for alzheimer's disease","volume":"19","author":"Brody","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.phrs.2025.107960_bib162","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/sctm.19-0327","article-title":"Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of alzheimer's disease","volume":"9","author":"Losurdo","year":"2020","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib163","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","article-title":"Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with alzheimer's disease dementia: a phase I clinical trial","volume":"13","author":"Kim","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib164","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41591-025-03559-0","article-title":"Allogeneic mesenchymal stem cell therapy with laromestrocel in mild alzheimer's disease: a randomized controlled phase 2a trial","volume":"31","author":"Rash","year":"2025","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trci.2015.06.007","article-title":"Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with alzheimer's disease dementia: a phase 1 clinical trial","volume":"1","author":"Kim","year":"2015","journal-title":"Alzheimers Dement (N. Y"},{"key":"10.1016\/j.phrs.2025.107960_bib166","unstructured":"The long-term safety and efficacy follow-up study of subjects who completed the Phase I Clinical Trial of Neurostem\u00ae-AD. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01696591\u3009 (2021)."},{"key":"10.1016\/j.phrs.2025.107960_bib167","unstructured":"The safety and the efficacy evaluation of NEUROSTEM\u00ae-AD in patients with Alzheimer's disease. 2021. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01297218\u3009."},{"key":"10.1016\/j.phrs.2025.107960_bib168","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib169","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.conb.2007.03.013","article-title":"Neurotrophins, synaptic plasticity and dementia","volume":"17","author":"Arancio","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107960_bib170","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107960_bib171","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/BRS.0b013e318059afab","article-title":"BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures","volume":"32","author":"Kamei","year":"2007","journal-title":"Spine (Philos. Pa 1976)"},{"key":"10.1016\/j.phrs.2025.107960_bib172","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/stem.1240","article-title":"Concise review: can stem cells be used to treat or model alzheimer's disease?","volume":"30","author":"Chen","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib173","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-020-0622-x","article-title":"Effects of neural stem cell transplantation in alzheimer's disease models","volume":"27","author":"Hayashi","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib174","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hipo.22405","article-title":"Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of alzheimer's disease and neuronal loss","volume":"25","author":"Ager","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.phrs.2025.107960_bib175","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hipo.22794","article-title":"NSCs promote hippocampal neurogenesis, metabolic changes and synaptogenesis in APP\/PS1 transgenic mice","volume":"27","author":"Zhang","year":"2017","journal-title":"Hippocampus"},{"key":"10.1016\/j.phrs.2025.107960_bib176","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.stemcr.2019.10.012","article-title":"Human neural stem cells reinforce hippocampal synaptic network and rescue cognitive deficits in a mouse model of alzheimer's disease","volume":"13","author":"Zhang","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib177","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1111\/j.1523-1755.2005.00623.x","article-title":"Stem cell therapy for human brain disorders","volume":"68","author":"Lindvall","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.phrs.2025.107960_bib178","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13619-022-00128-5","article-title":"The therapeutic prospects and challenges of human neural stem cells for the treatment of alzheimer's disease","volume":"11","author":"Yue","year":"2022","journal-title":"Cell Regen."},{"key":"10.1016\/j.phrs.2025.107960_bib179","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1046\/j.1460-9568.1998.00214.x","article-title":"Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells","volume":"10","author":"Andsberg","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107960_bib180","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1523\/JNEUROSCI.16-15-04604.1996","article-title":"Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells","volume":"16","author":"Mart\u00ednez-Serrano","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107960_bib181","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/sci-2021-063","article-title":"Advances in stem cell therapy in alzheimer's disease: a comprehensive clinical trial review","volume":"9","author":"Karvelas","year":"2022","journal-title":"Stem Cell Invest."},{"key":"10.1016\/j.phrs.2025.107960_bib182","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diff.2009.06.005","article-title":"Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in alzheimerian rats","volume":"78","author":"Moghadam","year":"2009","journal-title":"Differentiation"},{"key":"10.1016\/j.phrs.2025.107960_bib183","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071802","article-title":"Induced pluripotent stem Cell-Derived neural precursors improve memory, synaptic and pathological abnormalities in a mouse model of alzheimer's disease","volume":"10","author":"Armijo","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib184","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5966\/sctm.2016-0081","article-title":"Protein-Induced pluripotent stem cells ameliorate cognitive dysfunction and reduce A\u03b2 deposition in a mouse model of alzheimer's disease","volume":"6","author":"Cha","year":"2017","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib185","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112517","article-title":"Human pluripotent stem Cells-Based therapies for neurodegenerative diseases: current status and challenges","volume":"9","author":"Ford","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib186","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial alzheimer's disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107960_bib187","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","article-title":"Modeling familial alzheimer's disease with induced pluripotent stem cells","volume":"20","author":"Yagi","year":"2011","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.phrs.2025.107960_bib188","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/jnc.14809","article-title":"Parkinson's disease biomarkers based on \u03b1-synuclein","volume":"150","author":"Fayyad","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2025.107960_bib189","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2174\/1389557519666191104110908","article-title":"Parkinson's disease: a review from pathophysiology to treatment","volume":"20","author":"Marino","year":"2020","journal-title":"Mini Rev. Med Chem."},{"key":"10.1016\/j.phrs.2025.107960_bib190","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107960_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of parkinson's disease","volume":"196","author":"Mahoney-S\u00e1nchez","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107960_bib192","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(03)00684-6","article-title":"Caught in the act: alpha-synuclein is the culprit in parkinson's disease","volume":"40","author":"Eriksen","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107960_bib193","doi-asserted-by":"crossref","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","article-title":"Modeling parkinson's disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107960_bib194","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrn.2017.75","article-title":"Animal models of \u03b1-synucleinopathy for parkinson disease drug development","volume":"18","author":"Koprich","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2025.107960_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218060","article-title":"Stem Cell-Based therapies for parkinson disease","volume":"21","author":"Liu","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib196","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","article-title":"Animal models of parkinson's disease: bridging the gap between disease hallmarks and research questions","volume":"12","author":"Dovonou","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.phrs.2025.107960_bib197","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s12035-020-02201-z","article-title":"Pivotal role of fyn kinase in parkinson's disease and Levodopa-Induced dyskinesia: a novel therapeutic target?","volume":"58","author":"Angelopoulou","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107960_bib198","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2741\/4156","article-title":"Hematopoietic stem cells improve dopaminergic neuron in the MPTP-mice","volume":"18","author":"Lu","year":"2013","journal-title":"Front Biosci. (Landmark Ed. )"},{"key":"10.1016\/j.phrs.2025.107960_bib199","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2025.107960_bib200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0079-6123(10)84006-3","article-title":"Modeling neuroinflammatory pathogenesis of parkinson's disease","volume":"184","author":"Barnum","year":"2010","journal-title":"Prog. Brain Res"},{"key":"10.1016\/j.phrs.2025.107960_bib201","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41434-024-00451-3","article-title":"Long-term benefits of hematopoietic stem cell-based macrophage\/microglia delivery of GDNF to the CNS in a mouse model of parkinson's disease","volume":"31","author":"Ge","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2016.04.016","article-title":"Functional rescue of dopaminergic neuron loss in parkinson's disease mice after transplantation of hematopoietic stem and progenitor cells","volume":"8","author":"Altarche-Xifro","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2025.107960_bib203","article-title":"Mesenchymal stem cells for neurological disorders","volume":"8","author":"Andrzejewska","year":"2021","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.phrs.2025.107960_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107087","article-title":"The prospective role of mesenchymal stem cells in parkinson's disease","volume":"127","author":"Tambe","year":"2024","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.phrs.2025.107960_bib205","first-page":"435","article-title":"Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of parkinson's disease","author":"Bossolasco","year":"2012","journal-title":"Int J. Nanomed. 7"},{"issue":"1","key":"10.1016\/j.phrs.2025.107960_bib206","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.3727\/096368914X684970","article-title":"Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of alzheimer's and parkinson's disease","volume":"23","author":"Danielyan","year":"2014","journal-title":"Cell Transpl."},{"key":"10.1016\/j.phrs.2025.107960_bib207","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4252\/wjsc.v8.i3.106","article-title":"Updates in the pathophysiological mechanisms of parkinson's disease: emerging role of bone marrow mesenchymal stem cells","volume":"8","author":"Ahmed","year":"2016","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib208","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuint.2008.02.003","article-title":"Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of parkinson's disease","volume":"52","author":"Bouchez","year":"2008","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.phrs.2025.107960_bib209","doi-asserted-by":"crossref","DOI":"10.25259\/SNI_233_2020","article-title":"Mesenchymal stem cells in parkinson's disease: motor and nonmotor symptoms in the early posttransplant period","volume":"11","author":"Boika","year":"2020","journal-title":"Surg. Neurol. Int"},{"key":"10.1016\/j.phrs.2025.107960_bib210","first-page":"48","article-title":"TGF-\u03b21 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in parkinson's disease models and patients","volume":"11","author":"Zhuo","year":"2024","journal-title":"Mil. Med Res"},{"key":"10.1016\/j.phrs.2025.107960_bib211","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/exnr.1997.6634","article-title":"Long-term survival of human central nervous system progenitor cells transplanted into a rat model of parkinson's disease","volume":"148","author":"Svendsen","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib212","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010224","article-title":"Therapeutic potential of induced neural stem cells for parkinson's disease","volume":"18","author":"Choi","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107960_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.147978","article-title":"Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in parkinson's disease model","volume":"1790","author":"Ni","year":"2022","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2025.107960_bib214","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0963689718820271","article-title":"Transplantation of human neural progenitor cells (NPC) into putamina of parkinsonian patients: a case series study, safety and efficacy four years after surgery","volume":"28","author":"Madrazo","year":"2019","journal-title":"Cell Transpl."},{"key":"10.1016\/j.phrs.2025.107960_bib215","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jnnp-2023-332921","article-title":"Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in parkinson's disease","volume":"95","author":"Jiang","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107960_bib216","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of parkinson's disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107960_bib217","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for parkinson's disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107960_bib218","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature00900","article-title":"Dopamine neurons derived from embryonic stem cells function in an animal model of parkinson's disease","volume":"418","author":"Kim","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107960_bib219","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1634\/stemcells.2004-0094","article-title":"Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in parkinsonian rats","volume":"22","author":"Ben-Hur","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","article-title":"Preclinical efficacy and safety of a human embryonic stem Cell-Derived midbrain dopamine progenitor product, MSK-DA01","volume":"28","author":"Piao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2025.107960_bib221","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","article-title":"Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of parkinson's disease","volume":"15","author":"Grealish","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2025.107960_bib222","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2023.11.009","article-title":"Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on parkinson's disease","volume":"31","author":"Park","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2025.107960_bib223","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stemcr.2017.04.033","article-title":"Cryopreservation maintains functionality of human iPSC dopamine neurons and rescues parkinsonian phenotypes in vivo","volume":"9","author":"Wakeman","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib224","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/sctm.19-0396","article-title":"Preclinical safety studies of human embryonic stem cell-derived retinal pigment epithelial cells for the treatment of age-related macular degeneration","volume":"9","author":"Petrus-Reurer","year":"2020","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib225","article-title":"Can pluripotent\/multipotent stem cells reverse parkinson's disease progression?","volume":"18","author":"Wu","year":"2024","journal-title":"Front Neurosci."},{"key":"10.1016\/j.phrs.2025.107960_bib226","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-Derived dopamine progenitor cells for parkinson's disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib227","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.stemcr.2018.05.010","article-title":"Human Clinical-Grade parthenogenetic ESC-Derived dopaminergic neurons recover locomotive defects of nonhuman primate models of parkinson's disease","volume":"11","author":"Wang","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib228","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1288168","article-title":"Challenges involved in cell therapy for parkinson's disease using human pluripotent stem cells","volume":"11","author":"Moon","year":"2023","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2025.107960_bib229","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for parkinson's disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107960_bib230","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for parkinson's disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107960_bib231","first-page":"1613","article-title":"Amyotrophic lateral sclerosis (ALS) - diagnosis, course of disease and treatment options","volume":"146","author":"Meyer","year":"2021","journal-title":"Dtsch Med Woche"},{"key":"10.1016\/j.phrs.2025.107960_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116496","article-title":"Current therapy in amyotrophic lateral sclerosis (ALS): a review on past and future therapeutic strategies","volume":"272","author":"Wei","year":"2024","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.phrs.2025.107960_bib233","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainresbull.2023.01.008","article-title":"Cell therapy in ALS: an update on preclinical and clinical studies","volume":"194","author":"Sironi","year":"2023","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.phrs.2025.107960_bib234","doi-asserted-by":"crossref","DOI":"10.3390\/cells13171509","article-title":"Potential therapeutic interventions targeting NAD(+) metabolism for ALS","volume":"13","author":"Lundt","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107960_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147296","article-title":"Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model","volume":"1757","author":"Magota","year":"2021","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2025.107960_bib236","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jnr.22594","article-title":"Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"89","author":"Miyazaki","year":"2011","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.phrs.2025.107960_bib237","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/neup.12221","article-title":"Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis","volume":"35","author":"Sasaki","year":"2015","journal-title":"Neuropathology"},{"key":"10.1016\/j.phrs.2025.107960_bib238","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","article-title":"Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS","volume":"1157","author":"Garbuzova-Davis","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2025.107960_bib239","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001205","article-title":"Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS","volume":"2","author":"Garbuzova-Davis","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107960_bib240","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2004.06.009","article-title":"Lessons from models of SOD1-linked familial ALS","volume":"10","author":"Bendotti","year":"2004","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib241","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002494","article-title":"Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose","volume":"3","author":"Garbuzova-Davis","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107960_bib242","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031254","article-title":"Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS","volume":"7","author":"Garbuzova-Davis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107960_bib243","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41598-017-00993-0","article-title":"Endothelial and astrocytic support by human bone marrow stem cell grafts into symptomatic ALS mice towards Blood-Spinal cord barrier repair","volume":"7","author":"Garbuzova-Davis","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib244","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1038\/s41598-019-41747-4","article-title":"Human bone marrow endothelial progenitor cell transplantation into symptomatic ALS mice delays disease progression and increases motor neuron survival by repairing Blood-Spinal cord barrier","volume":"9","author":"Garbuzova-Davis","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/14653240802549470","article-title":"Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up","volume":"11","author":"Deda","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.phrs.2025.107960_bib246","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/01.wnl.0000327668.43541.22","article-title":"Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis","volume":"71","author":"Appel","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107960_bib247","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/14653240701376413","article-title":"Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice","volume":"9","author":"Zhao","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.phrs.2025.107960_bib248","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2119\/molmed.2011.00498","article-title":"Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis","volume":"18","author":"Uccelli","year":"2012","journal-title":"Mol. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib249","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/sctm.18-0223","article-title":"A combination of intrathecal and intramuscular application of human mesenchymal stem cells partly reduces the activation of necroptosis in the spinal cord of SOD1(G93A) rats","volume":"8","author":"\u0158eho\u0159ov\u00e1","year":"2019","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib250","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.scr.2017.11.005","article-title":"Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice","volume":"25","author":"Sironi","year":"2017","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.phrs.2025.107960_bib251","doi-asserted-by":"crossref","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","article-title":"NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results","volume":"93","author":"Berry","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107960_bib252","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/mus.27472","article-title":"A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis","volume":"65","author":"Cudkowicz","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.phrs.2025.107960_bib253","doi-asserted-by":"crossref","first-page":"693","DOI":"10.52586\/4980","article-title":"A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis","volume":"26","author":"Petrou","year":"2021","journal-title":"Front Biosci. (Landmark Ed."},{"key":"10.1016\/j.phrs.2025.107960_bib254","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s12015-020-10016-7","article-title":"Umbilical cord mesenchymal stem cells in amyotrophic lateral sclerosis: an original study","volume":"16","author":"Barczewska","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib255","doi-asserted-by":"crossref","DOI":"10.1177\/09636897231214370","article-title":"Safety and clinical effects of a muse Cell-Based product in patients with amyotrophic lateral sclerosis: results of a phase 2 clinical trial","volume":"32","author":"Yamashita","year":"2023","journal-title":"Cell Transpl."},{"key":"10.1016\/j.phrs.2025.107960_bib256","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.927484","article-title":"Repeat administration of bone Marrow-Derived mesenchymal stem cells for treatment of amyotrophic lateral sclerosis","volume":"26","author":"Siwek","year":"2020","journal-title":"Med Sci. Monit."},{"key":"10.1016\/j.phrs.2025.107960_bib257","doi-asserted-by":"crossref","DOI":"10.2174\/011574888X330199250106081717","article-title":"Evaluation of safety and efficacy of repeated mesenchymal stem cell transplantation in patients with amyotrophic lateral sclerosis (ALS) by investigating patient's specific microRNAs as novel biomarkers: a clinical trial study","author":"Alkhazaali-Ali","year":"2025","journal-title":"Curr. Stem Cell Res Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib258","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004579","article-title":"Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis","volume":"4","author":"Teng","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib259","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107960_bib260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1789.2007.00858.x","article-title":"Stem cell-based cell therapy for huntington disease: a review","volume":"28","author":"Kim","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.phrs.2025.107960_bib261","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/gt.2009.80","article-title":"Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice","volume":"16","author":"Hwang","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.phrs.2025.107960_bib262","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41419-019-1582-5","article-title":"Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats","volume":"10","author":"Zalfa","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.107960_bib263","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","article-title":"Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats","volume":"82","author":"Xu","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2025.107960_bib264","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/exnr.2002.7860","article-title":"Positive effect of transplantation of hNT neurons (NTera 2\/D1 cell-line) in a model of familial amyotrophic lateral sclerosis","volume":"174","author":"Garbuzova-Davis","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib265","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/term.1972","article-title":"Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors","volume":"11","author":"Knippenberg","year":"2017","journal-title":"J. Tissue Eng. Regen. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib266","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.24113","article-title":"Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes","volume":"75","author":"Feldman","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2025.107960_bib267","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/sctm.18-0154","article-title":"Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a Long-Term outcome","volume":"8","author":"Mazzini","year":"2019","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib268","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12967-014-0371-2","article-title":"Human neural stem cell transplantation in ALS: initial results from a phase I trial","volume":"13","author":"Mazzini","year":"2015","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib269","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.neuron.2023.01.010","article-title":"Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects","volume":"111","author":"Workman","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107960_bib270","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25082000","article-title":"Induced pluripotent stem cell (iPSC)-Based neurodegenerative disease models for phenotype recapitulation and drug screening","volume":"25","author":"Chang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2025.107960_bib271","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5966\/sctm.2012-0042","article-title":"Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis","volume":"2","author":"Popescu","year":"2013","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.phrs.2025.107960_bib272","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.stemcr.2023.03.016","article-title":"Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration","volume":"18","author":"Laperle","year":"2023","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib273","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.stemcr.2014.05.017","article-title":"Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice","volume":"3","author":"Kondo","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2025.107960_bib274","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/17482960902933809","article-title":"Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: a pilot study","volume":"11","author":"Nefussy","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.phrs.2025.107960_bib275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13024-017-0227-3","article-title":"Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis","volume":"12","author":"Ciervo","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2025.107960_bib276","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nature04960","article-title":"Stem cells for the treatment of neurological disorders","volume":"441","author":"Lindvall","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107960_bib277","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.111882","article-title":"Human artificial chromosomes for pluripotent stem cell-based tissue replacement therapy","volume":"389","author":"Sinenko","year":"2020","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.phrs.2025.107960_bib278","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115134","article-title":"Hypoimmunogenic pluripotent stem cells: a game-changer in cell-based regenerative Medicine","volume":"162","author":"Asadi-Sarabi","year":"2025","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.phrs.2025.107960_bib279","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cei.13358","article-title":"Self-reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center","volume":"198","author":"Ruiz-Arg\u00fcelles","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.phrs.2025.107960_bib280","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/s41591-022-01956-3","article-title":"Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial","volume":"28","author":"Baloh","year":"2022","journal-title":"Nat. Med"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:07:55Z","timestamp":1773126475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825003858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":280,"alternative-id":["S1043661825003858"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107960","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cells therapy in neurodegenerative and neuroimmune diseases: Current status of treatments and future prospects","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107960"}}